Raymond James Financial
PFE icon

Raymond James Financial’s Pfizer PFE Stock Holding History

Raymond James Financial’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,000
Closed -$490K – 5416
2025
Q4 		$490K Buy
+14,000
New +$353K ﹤0.01% 4282

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Raymond James Financial's PFE Position: Q1 2026 in Review

Raymond James Financial increased its Pfizer (PFE) stake by 1.6% in Q1 2026, buying an estimated $4.99M and bringing the position to 11,674,216 shares worth $328M. The position accounts for 0.1% of the portfolio, ranked #175.

Raymond James Financial first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. 2,946 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Raymond James Financial held 11,674,216 shares of Pfizer worth $328M as of Q1 2026.
  • Raymond James Financial bought 187,503 Pfizer shares in Q1 2026, an estimated $4.99M.
  • Pfizer made up 0.1% of Raymond James Financial's portfolio in Q1 2026, its #175 holding.
  • Raymond James Financial first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • 2,946 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.